Clinical Trials in Illinois (IL) | Illinois Clinical Drug Trials & Studies

You are viewing Clinical Trials In Illinois

Have multiple conditions? Click here

Showing 1-100 of 4452

There are 4452 trials in Illinois

Name	City	State	Zip
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer	Zion	IL	60099
A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients	Zion	IL	60099
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer	Zion	IL	60099
Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer	Zion	IL	60099
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer	Yorkville	IL	60560
An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer	Winfield	IL	60190
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis	Winfield	IL	60190
Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse	Winfield	IL	60190
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI	Winfield	IL	60190
The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis	Winfield	IL	60190
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy	Winfield	IL	60190
Dilute Betadine Lavage in the Prevention of Postoperative Infection	Winfield	IL	60190
A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Small Cell Lung Cancer (SCLC)	Winfield	IL	60190
A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Small Cell Lung Cancer (SCLC)	Winfield	IL	60190
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Winfield	IL	60190
Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations	Winfield	IL	60190
Comparison of Two Intermittent Urinary Catheters	Wheeling	IL
WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients	Wheaton	IL	60187
Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print	Waukegan	IL	60085
Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects	Waukegan	IL	60085
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer	Warrenville	IL	60555
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Warrenville	IL	60555
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	Warrenville	IL	60555
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Warrenville	IL	60555
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma	Warrenville	IL	60555
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia	Warrenville	IL	60555
A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer	Warrenville	IL	60555
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy	Warrenville	IL	60555
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	Warrenville	IL	60555
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer	Warrenville	IL	60555
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Warrenville	IL	60555
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Warrenville	IL	60555
Study of Hypo-fractionated Proton Radiation for Prostate Cancer	Warrenville	IL	60555
Registry Study for Proton Therapy Outcomes	Warrenville	IL	60555
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)	Vernon Hills	IL	60061
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme	Urbana	IL	61801
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors	Urbana	IL	61801
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors	Urbana	IL	61801
Intra-Cardiac Echocardiography Guided Cardioversion to Help Interventional Procedures (ICE-CHIP) Study	Urbana	IL	61801
Domperidone for Relief of Gastrointestinal Disorders	Urbana	IL	61801
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Urbana	IL	61801
PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma	Urbana	IL	61801
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer	Urbana	IL	61801
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer	Urbana	IL	61801
Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia	Urbana	IL	61801
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases	Urbana	IL	61801
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer	Urbana	IL	61801
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer	Urbana	IL	61801
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer	Urbana	IL	61801
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer	Urbana	IL	61801
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Urbana	IL	61801
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer	Urbana	IL	61801
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer	Urbana	IL	61801
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Urbana	IL	61801
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma	Urbana	IL	61801
VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer	Urbana	IL	61801
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	Urbana	IL	61801
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy	Urbana	IL	61801
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Urbana	IL	61801
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Urbana	IL	61801
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Urbana	IL	61801
Acute Pain Caused by Paclitaxel in Patients With Cancer	Urbana	IL	61801
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	Urbana	IL	61801
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Urbana	IL	61801
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial	Urbana	IL	61801
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy	Urbana	IL	61801
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer	Urbana	IL	61801
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Urbana	IL	61801
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	Urbana	IL	61801
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers	Urbana	IL	61801
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery	Urbana	IL	61801
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Urbana	IL	61801
A Study Evaluating the Clinical Benefit of Adding Custirsen to Docetaxel Retreatment/Prednisone as Second Line Therapy in Men With Castrate Resistant Prostate Cancer (CRPC)	Urbana	IL	61801
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer	Urbana	IL	61801
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy	Urbana	IL	61801
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma	Urbana	IL	61801
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Urbana	IL	61801
Incentives for Preventative Health Care: Increasing Completion of Health Risk Assessments	Tinley Park	IL
Insulin Resistance Intervention After Stroke Trial	St. Charles	IL	60175
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma	Springfield	IL	62794
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors	Springfield	IL	62794
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Springfield	IL	62794
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Springfield	IL	62794
Decitabine in Treating Patients With Myelofibrosis	Springfield	IL	62794
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer	Springfield	IL	62794
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor	Springfield	IL	62794
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors	Springfield	IL	62794
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma	Springfield	IL	62794
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Springfield	IL	62794
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma	Springfield	IL	62794
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes	Springfield	IL	62794
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia	Springfield	IL	62794
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor	Springfield	IL	62794
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	Springfield	IL	62794
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Springfield	IL	62794
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Springfield	IL	62794
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Springfield	IL	62794
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies	Springfield	IL	62794
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors	Springfield	IL	62794
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	Springfield	IL	62794

View Clinical Trial Facilities in Illinois

Showing 1-100 of 4452